Oxford PharmaGenesis has been listed in the latest Agency 100 by Medical Marketing and Media

Oxford PharmaGenesis has been listed in the latest Agency 100 by Medical Marketing and Media.

The 2021 ranking is grounded on information about healthcare communications companies’ 2020 results. The ranking highlights the key players in a fast-evolving and competitive field and is an important gauge of the sector’s health.

Oxford PharmaGenesis met the exact criteria set by Medical Marketing and Media and demonstrated significantly strong growth.

Chris Winchester, Oxford PharmaGenesis’ CEO, stated: “This is a hugely important award for agencies in our sector in North America. We’re very proud to be recognised for the quality of our work with clients, and the ongoing success of the company. Congratulations in particular to the team in our Philadelphia office for their commitment to the Oxford PharmaGenesis standards of quality and service. This ranking is truly well earned.”

Executive Vice President, Oxford PharmaGenesis US office, Brain Falcone, stated: “I am thrilled that the hard work of our colleagues across the world has allowed us to secure this designation. We have some remarkable people here at Oxford PharmaGenesis and their contributions absolutely deserve recognition.”